1. Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France). (16th September 2015) Authors: Long, E.; Ilie, M.; Lassalle, S.; Butori, C.; Poissonnet, G.; Washetine, K.; Mouroux, J.; Lespinet, V.; Lacour, J.P.; Taly, V.; Laurent‐Puig, P.; Bahadoran, P.; Hofman, V.; Hofman, P. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 12(2015:Dec.) Page Start: 2436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗